News | April 27, 2022
Syngene full-year revenue from operations up 19% to Rs. 2604 crore
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
The company also plans to expand the facility
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
Expands manufacturing push & locks in major growth deals
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
Subscribe To Our Newsletter & Stay Updated
